Approval · Notice of Compliance 37579 · 2026
METFORMIN: Notice of Compliance 37579
Issued May 20, 2026
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 37579
- Date
- May 20, 2026
- Company
- Sivem Pharmaceuticals UlcSaint-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- Administrative: Licensing Agreement between two manufacturers
- Canadian reference product
- GLUCOPHAGE
Products in this notice
Medicinal ingredients
- METFORMIN HYDROCHLORIDE 500 MG per UNIT
- METFORMIN HYDROCHLORIDE 850 MG per UNIT